Singapore firm that developed COVID-19 breath test pivoted from detecting lung cancer to coronavirus

SINGAPORE: When COVID-19 hit Singapore early last year, local start-up Breathonix had to stop all its clinical trials for its lung cancer breathalyser test due to pandemic restrictions.

The company’s CEO Dr Jia Zhunan had been working on a way to detect disease from a person’s breath since her …